PDL BioPharma and Paradigm Spinee enter into $75M credit agreement PDL BioPharma and Paradigm Spine announced that the parties have entered into a credit agreement whereby PDL will provide Paradigm with up to $75m of secured debt financing. Armentum Partners acted as financial advisors to Paradigm Spine for the transaction. An initial $50M was provided at the close of the transaction, with the remaining $25M to be funded in two equal tranches upon achievement of specified milestones.
News For PDLI From The Last 14 Days
Check below for free stories on PDLI the last two weeks.